AU6166396A - Complexes of modified lymphotoxins as pharmaceutical prepara tions - Google Patents

Complexes of modified lymphotoxins as pharmaceutical prepara tions

Info

Publication number
AU6166396A
AU6166396A AU61663/96A AU6166396A AU6166396A AU 6166396 A AU6166396 A AU 6166396A AU 61663/96 A AU61663/96 A AU 61663/96A AU 6166396 A AU6166396 A AU 6166396A AU 6166396 A AU6166396 A AU 6166396A
Authority
AU
Australia
Prior art keywords
lymphotoxins
complexes
modified
pharmaceutical prepara
prepara tions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61663/96A
Inventor
Jeffrey L Browning
Michael N. Karpusas
Werner Meier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen Inc
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of AU6166396A publication Critical patent/AU6166396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU61663/96A 1995-06-07 1996-06-06 Complexes of modified lymphotoxins as pharmaceutical prepara tions Abandoned AU6166396A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47607495A 1995-06-07 1995-06-07
US476074 1995-06-07
PCT/US1996/009773 WO1996040774A1 (en) 1995-06-07 1996-06-06 Complexes of modified lymphotoxins as pharmaceutical preparations

Publications (1)

Publication Number Publication Date
AU6166396A true AU6166396A (en) 1996-12-30

Family

ID=23890401

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61663/96A Abandoned AU6166396A (en) 1995-06-07 1996-06-06 Complexes of modified lymphotoxins as pharmaceutical prepara tions

Country Status (2)

Country Link
AU (1) AU6166396A (en)
WO (1) WO1996040774A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599719B2 (en) * 1994-11-07 2003-07-29 Human Genome Sciences, Inc. Nucleic acid molecules encoding tumor necrosis factor-gamma-alpha
KR100618492B1 (en) * 1997-09-12 2006-08-31 아포시스 에스에이 April-a novel protein with growth effects
CN1269832A (en) * 1997-09-12 2000-10-11 阿普泰克研究与开发公司 Kay-novel immune system protein
EP1992633A1 (en) * 1997-11-03 2008-11-19 Human Genome Sciences, Inc. VEGI, an inhibitor of angiogenesis and tumor growth
WO2001025277A1 (en) * 1999-10-07 2001-04-12 Maxygen Aps Single-chain antagonist polypeptides
AU2002223032A1 (en) * 2000-10-26 2002-05-06 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Hetero-oligomeric compounds derived from the tnf cytokine superfamily and their use
WO2007054658A1 (en) * 2005-11-14 2007-05-18 King's College London Control of immune responses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2086264C (en) * 1990-06-27 2002-12-24 Jeffrey L. Browning Surface complexed lymphotoxin
ATE397665T1 (en) * 1992-12-04 2008-06-15 Biogen Idec Inc LYMPHOTOXIN-BETA, LYMPHOTOXIN-BETA COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF

Also Published As

Publication number Publication date
WO1996040774A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
AU6216296A (en) Pharmaceutical compositions
AU6995396A (en) Pharmaceutical formulation
AUPN411195A0 (en) Medicinal composition
AU6011496A (en) Improved pharmaceutical compositions for gene therapy
AU7572196A (en) Pharmaceutical formulations
AU7590096A (en) Drug composition
AU6418596A (en) Compounds and pharmaceutical compositions containing them
AU6973396A (en) Pharmaceutical formulation
AU6904896A (en) Pharmaceutical compounds
AU6165196A (en) Stable formulations of mhc-peptide complexes
AU7000796A (en) Heteroaryl-substituted acryloylguanidine derivatives and pharmaceutical compositions comprising them
AU6858996A (en) Pharmaceutical compositions for the treatment of infectious diseases
AU5155096A (en) Pharmaceutical composition
EP0747346A3 (en) N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
AU5274096A (en) Pharmaceutical compositions
AU6835996A (en) Pyridinium derivatives and pharmaceutical compositions containing them
AU2531295A (en) Pharmaceutical composition
AU7582696A (en) Pharmaceutical formulation
AU5326298A (en) Pharmaceutical compositions containing N-sulphonylindoline derivatives
AU6166396A (en) Complexes of modified lymphotoxins as pharmaceutical prepara tions
AU1475595A (en) Pharmaceutical preparation
AU3710695A (en) Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them
AU6875096A (en) Pharmaceutical composition with trypanocidal properties
AUPN727595A0 (en) Therapeutic compositions
AU7546096A (en) Pharmaceutical compounds